$22.38
0.02[0.09%]
At close: Apr 29
$22.38
0[0.00%]
After Hours: 5:20PM EDT
Landos Biopharma
(NASDAQ:LABP)Latest News for Landos Biopharma Stock (NASDAQ:LABP)
Landos Biopharma Stock (NASDAQ: LABP)
Categories: All
Friday, April 26, 2024
Monday, April 01, 2024
Monday, March 25, 2024
- Nasdaq Turns Higher; Akanda Shares PlungeAvi Kapoor - Mar 25, 2024, 3:00PM
- Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Mar 25, 2024, 2:44PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Mar 25, 2024, 1:30PM
- Crude Oil Moves Higher; US New Home Sales Fall In FebruaryAvi Kapoor - Mar 25, 2024, 11:54AM
- Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?Vandana Singh - Mar 25, 2024, 11:27AM
- Landos Biopharma shares are trading higher after the company announced that it entered into a definitive agreement to be acquired by AbbVie.Benzinga Newsdesk - Mar 25, 2024, 10:54AM
- US Stocks Down; Chicago Fed National Activity Index Rises In FebruaryAvi Kapoor - Mar 25, 2024, 9:42AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Mar 25, 2024, 9:05AM
- AbbVie To Acquire Landos Biopharma At A Price Of $20.42 Per Share In Cash Upon Closing, Or ~$137.5MBenzinga Newsdesk - Mar 25, 2024, 8:32AM
- Trading Halt: Halted at 8:25:00 a.m. ET - Trading Halt: Halt News PendingBenzinga Newsdesk - Mar 25, 2024, 8:25AM
Thursday, March 21, 2024
Monday, January 08, 2024
Tuesday, November 21, 2023
Thursday, November 09, 2023
Tuesday, September 19, 2023
Thursday, September 14, 2023
Wednesday, August 09, 2023
Tuesday, June 13, 2023
Thursday, June 08, 2023
Thursday, May 25, 2023
- Landos Biopharma Plans To Effect 1-For-10 Reverse Stock SplitBenzinga Newsdesk - May 25, 2023, 4:11PM
- Landos Biopharma Director Awarded $5K Worth of Stock OptionsBenzinga Insights - May 25, 2023, 11:01AM
- Landos Biopharma Board Member Awarded $5K Worth of Stock OptionsBenzinga Insights - May 25, 2023, 11:01AM
- Director at Landos Biopharma Acquires Company Stock Options Worth 18,000 SharesBenzinga Insights - May 25, 2023, 11:01AM
- Board Member at Landos Biopharma Acquires Company Stock Options Worth 18,000 SharesBenzinga Insights - May 25, 2023, 11:01AM
Friday, May 12, 2023
Wednesday, April 12, 2023
Thursday, March 23, 2023
Saturday, March 11, 2023
Friday, March 10, 2023
Thursday, March 09, 2023
Wednesday, March 08, 2023
Wednesday, March 01, 2023
Tuesday, February 28, 2023
Thursday, February 09, 2023
Friday, January 13, 2023
Wednesday, January 11, 2023
- Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Jan 11, 2023, 1:15PM
- Landos Biopharma shares are trading higher after the company's NX-13 Phase 1b abstract was accepted for poster presentation by the 18th Congress of the European Crohn's and Colitis Organization.Michael Horton - Jan 11, 2023, 10:17AM
- Landos Biopharma Announces Acceptance Of Abstract On NX-13 Phase 1b Study In Ulcerative Colitis At 18th Annual Congress Of The European Crohn's And Colitis OrganizationBill Haddad - Jan 11, 2023, 7:10AM
Friday, January 06, 2023
- Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Jan 6, 2023, 1:16PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Jan 6, 2023, 12:30PM
- Landos Biopharma shares are trading lower after Jefferies downgraded the stock from Hold to Underperform and lowered its price target from $0.20 to $0.10.Michael Horton - Jan 6, 2023, 10:44AM
- Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023Benzinga Insights - Jan 6, 2023, 10:00AM
- Jefferies Downgrades Landos Biopharma to Underperform, Lowers Price Target to $0.1Benzinga Newsdesk - Jan 6, 2023, 6:09AM